Innate Pharma SA (IPHA)
1.53
+0.05
(+3.38%)
USD |
NASDAQ |
Oct 09, 14:08
Innate Pharma Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 2.704 |
| Cellectis SA | 3.090 |
| Genfit SA | -- |
| Inventiva SA | 1.777 |
Price to Book Value Related Metrics
| PS Ratio | 29.07 |
| PEG Ratio | -0.0874 |
| Price | 1.53 |
| Earnings Yield | -38.59% |
| Market Cap | 143.67M |
| PEGY Ratio | -0.0874 |